Archive: 02/01/2013

Ravicti approved for urea cycle disorders

(HealthDay)—Ravicti (glycerol phenylbutyrate) has been approved by the U.S. Food and Drug Administration to treat certain urea cycle disorders (UCDs) in people 2 years and older.

Feb 01, 2013
popularity not rated yet | comments 0

Caring friends can save the world

Craig Kielburger was only 12 years old when he travelled to India to see the plight of child laborers first hand. 14-year-old Malala Yousafzai took a stand against the Taliban with her campaign for women's education rights. ...

Feb 01, 2013
popularity 4 / 5 (1) | comments 0

Propping open the door to the blood brain barrier

The treatment of central nervous system (CNS) diseases can be particularly challenging because many of the therapeutic agents such as recombinant proteins and gene medicines are not easily transported across the blood-brain ...

Feb 01, 2013
popularity not rated yet | comments 0

Autism speaks through gene expression

Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis ...

Feb 01, 2013
popularity 3 / 5 (2) | comments 0 | with audio podcast

Low adiponectin in first trimester linked to GDM

(HealthDay)—Low adiponectin levels during the first trimester of pregnancy correlate with a higher level of insulin resistance and an increased risk of developing gestational diabetes mellitus (GDM), according ...

Feb 01, 2013
popularity not rated yet | comments 0